Efficacy and Safety of Orelabrutinib for Previously Treated Marginal Zone Lymphoma
{{output}}
Background: This study aimed to investigate the efficacy and safety of orelabrutinib monotherapy in Chinese patients with marginal zone B-cell lymphoma (MZL). Met... ...
